| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 737.32M | 711.16M | 741.62M | 681.16M | 595.62M |
| Gross Profit | 295.55M | 266.13M | 285.44M | 247.08M | 243.04M |
| EBITDA | 65.25M | 3.08M | 91.03M | 54.16M | 41.94M |
| Net Income | 76.12M | -20.10M | 85.90M | 32.30M | 19.36M |
Balance Sheet | |||||
| Total Assets | 819.47M | 759.21M | 807.56M | 719.34M | 721.08M |
| Cash, Cash Equivalents and Short-Term Investments | 285.71M | 216.52M | 179.98M | 114.01M | 132.39M |
| Total Debt | 6.95M | 6.07M | 6.49M | 6.92M | 46.01M |
| Total Liabilities | 122.91M | 124.41M | 135.08M | 129.63M | 149.98M |
| Stockholders Equity | 717.29M | 657.20M | 696.57M | 617.84M | 602.84M |
Cash Flow | |||||
| Free Cash Flow | 79.08M | 48.52M | 67.46M | 21.80M | 24.41M |
| Operating Cash Flow | 103.76M | 67.70M | 91.96M | 37.16M | 37.03M |
| Investing Cash Flow | -16.20M | -21.17M | -17.56M | 17.66M | 4.50M |
| Financing Cash Flow | -19.59M | -19.57M | -4.33M | -39.84M | -53.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$470.70M | 6.04 | 10.82% | 4.07% | 2.77% | -110.76% | |
74 Outperform | HK$83.30B | 13.36 | 14.96% | 4.69% | 1.51% | 5.50% | |
68 Neutral | HK$88.24B | -8.03 | 1.45% | 3.42% | -0.31% | 10.85% | |
63 Neutral | HK$101.78B | 26.31 | 8.50% | 5.59% | -9.54% | -27.75% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$1.77B | 7.35 | 12.24% | ― | 153.95% | 551.46% | |
54 Neutral | HK$308.44M | 26.24 | 4.24% | 1.30% | -4.14% | -21.15% |